The Putative Antilipogenic Role of NRG4 and ERBB4: First Expression Study on Human Liver Samples

The Putative Antilipogenic Role of NRG4 and ERBB4: First Expression Study on Human Liver Samples

Background: Epidermal growth factor receptor 4 (ERBB4) and neuregulin 4 (NRG4) have been shown to reduce steatosis and prevent the development of non-alcoholic steatohepatitis in mouse models, but little to nothing is known about their role in non-alcoholic fatty liver disease (NA...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Bograya, Maria Vulf, Anastasia Minchenko, Natalia Gazatova, Georgy Kuznetsov, Natalia Todosenko, Larisa Volkova, Pavel Ivanov, Larisa Litvinova
Format: Article
Language:English
Published: IMR Press 2024-12-01
Series:Frontiers in Bioscience-Landmark
Subjects:
erbb4
nrg4
obesity
nafld
steatosis
nash
Online Access:https://www.imrpress.com/journal/FBL/29/12/10.31083/j.fbl2912414
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items